카타란틴 시장 : 제품 유형별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Catharanthine Market size was valued at USD 823.32 Million in 2023, expanding at a CAGR of 3.5% from 2024 to 2032.

Catharanthine, a unique molecule found in the medicinal plant Catharanthus roseus (also known as Madagascar periwinkle), belongs to a class of compounds called monoterpenoid indole alkaloids. It boasts a complex structure, featuring a bridged ring system, a methyl ester group, and a tertiary amine. Notably, catharanthine serves as a crucial building block in the synthesis of vinblastine, a powerful chemotherapy drug used against various cancers. Catharanthine itself holds promise in the realm of medicine. Catharanthine sulfate, a specific salt form, exhibits anti-tumor activity, while catharanthine tartrate acts as a valuable starting material for the production of anti-cancer medications. This highlights the potential of catharanthine beyond its role as a precursor. Given its diverse applications in healthcare and pharmaceuticals, the market for catharanthine is anticipated to see continued growth.

Catharanthine Market- Market Dynamics

Rising per capita healthcare spending and increasing cancer incidence to propel market demand

Rising per capita healthcare spending and increasing cancer incidence are expected to propel the Catharanthine Market. According to OECD Health Statistics, in 2019, per capita health spending in the U.S. exceeded $10,000, more than double that of countries like Australia, New Zealand, France, Canada, and the U.K. The U.S. also leads in per capita spending on private health insurance premiums at $4,092, which is more than five times higher than Canada, the second-highest spender. In contrast, private spending in Sweden and Norway is less than $100 per capita. Private spending in the U.S. accounts for 40% of total health spending, significantly higher than other countries, where it ranges from 0.3% to 15%. The average U.S. resident paid $1,122 out-of-pocket for healthcare, more than double what residents of France and New Zealand pay. This increasing healthcare expenditure, especially in private spending, highlights the growing demand for effective treatments. Additionally, the global cancer burden has risen dramatically, with the (IARC) International Agency for Research on Cancer reporting 19.3 million new cases and 10 million cancer deaths in 2020. In the United States alone, the National Cancer Institute projected 1,806,590 new cancer diagnoses and 606,520 deaths in 2020. This rising incidence of cancer underscores the urgent need for effective treatments, including those derived from Catharanthine, thereby driving market growth.

Catharanthine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.5% over the forecast period (2024-2032)

Based on Product Type segmentation, catharanthine sulfate was predicted to show maximum market share in the year 2023

Based on Application segmentation, pharmaceutical was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Catharanthine Market- Segmentation Analysis:

The Global Catharanthine Market is segmented based on Product Type, Application, and Region.

The market is divided into two categories based on Product Type: Catharanthine sulfate and Catharanthine tartrate. In 2023, the catharanthine sulfate segment held the largest share of the Catharanthine Market. Catharanthine sulfate, a vinblastine-type alkaloid precursor, exhibits antitumor activity by inhibiting the acetylcholine receptor (AChR) through ion channel blocking and desensitization. Meanwhile, catharanthine tartrate serves as a precursor for synthesizing vinblastine and vincristine, with vincristine being more neurotoxic than vinblastine. These vinca alkaloids are cell cycle-specific antitumor agents that bind to tubulin, preventing its polymerization into microtubules, and arresting cell division at metaphase. This disruption of mitosis leads to cell death. Vincristine, a widely used pediatric chemotherapeutic agent, treats both hematologic malignancies and solid tumors by inducing apoptosis through interference with microtubule assembly. The pivotal roles of catharanthine sulfate and catharanthine tartrate in cancer treatment are driving growth in the Catharanthine Market.

The market is divided into three categories based on Application: Pharmaceutical, Food and Beverages and Others. The pharmaceutical segment also dominated the Catharanthine Market in 2023. Key indole alkaloids like vinblastine (VLB) and vincristine (VCR) are clinically essential anticancer agents. Vinblastine is used systemically for treating leukemias, lymphomas, non-Hodgkin lymphoma, breast cancer, and testicular cancer. Vincristine stands out as a frequently employed chemotherapy drug in pediatric oncology, tackling hematologic malignancies and solid tumors. According to the International Agency for Research on Cancer (IARC), approximately 19.3 million new cancer cases and roughly 10 million cancer-related deaths were documented worldwide in 2020. These statistics underscore the reality that over 50 million individuals are navigating life within five years of a cancer diagnosis. Consequently, there's a heightened demand anticipated for therapies derived from catharanthine, reflecting the need for such treatments in the foreseeable future.

Catharanthine Market- Geographical Insights

The geographic scope of this market encompasses North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, specific countries define distinct market segments. In 2023, North America held the largest share in the Catharanthine Market, driven by the rising prevalence of chronic diseases like cancer. According to the International Journal of Environmental Research and Public Health, the global pharmaceutical market has significantly increased, with E7 countries such as India, Brazil, China, Indonesia, Mexico, Russia, and Turkey accounting for one-fifth of global pharmaceutical sales. Developed markets are expected to see a $298 billion increase in brand spending over five years, primarily driven by new products and price increases in the U.S. China's pharmaceutical market is also growing rapidly, projected to reach $161.8 billion by 2023, holding a 30% share of the global market. As the world's second-largest pharmaceutical market, China's growth significantly influences the global Catharanthine Market.

Catharanthine Market- Competitive Landscape:

In the Catharanthine market, key players employ strategic initiatives such as partnerships and research advancements to maintain their competitive edge. Collaborations with pharmaceutical companies, research institutions, and agricultural organizations ensure a reliable supply of high-quality catharanthine, an alkaloid derived from the Madagascar periwinkle plant (Catharanthus roseus). These partnerships support sustainable cultivation practices, securing a consistent source of raw materials for the pharmaceutical industry. Moreover, alliances with drug developers and academic researchers drive innovation in catharanthine-based medications, especially for cancer treatment and other diseases. Continuous research into extraction methods, purification techniques, and synthesis pathways further enhances the efficiency and cost-effectiveness of catharanthine production, enabling companies to meet the growing demand for this valuable natural compound. Through strategic partnerships and research advancements, companies in the Catharanthine market can maintain market leadership, foster drug development innovation, and contribute to healthcare advancements.

Recent Developments:

As per the findings published in the 2022 volume of BioDesign Research on December 26, 2022, a research team from China, Zhejiang University has made a breakthrough by discovering a method for the biological synthesis of catharanthine and vindoline, the two pharmacological precursors of vinblastine. Previously, it was known that the biosynthesis of these precursors involves a 31-step reaction in Catharanthus roseus, a medicinal and ornamental plant. Inspired by this process, the research team genetically engineered Saccharomyces cerevisiae, commonly known as yeast, to produce vindoline and catharanthine. They then used chemical and biological coupling to convert these compounds into vinblastine.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CATHARANTHINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

AK Scientific Inc

Stanford Chemicals

Cayman Chemicals

Bio Vision Inc

Enzo Biochem Inc

Hainan Yueyang Biotech Co Ltd

Abcam

ChemFaces

Others

GLOBAL CATHARANTHINE MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

• Catharanthine sulfate
• Catharanthine tartrate

GLOBAL CATHARANTHINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Pharmaceutical
• Food and Beverages
• Others

GLOBAL CATHARANTHINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Catharanthine Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Catharanthine Market Snippet by Product Type
  • 2.1.2. Catharanthine Market Snippet by Application
  • 2.1.3. Catharanthine Market Snippet by Country
  • 2.1.4. Catharanthine Market Snippet by Region
• 2.2. Competitive Insights

3. Catharanthine Key Market Trends

• 3.1. Catharanthine Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Catharanthine Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Catharanthine Market Opportunities
• 3.4. Catharanthine Market Future Trends

4. Catharanthine Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Catharanthine Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Catharanthine Market Landscape

• 6.1. Catharanthine Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Catharanthine Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
  • 7.1.2. Catharanthine sulfate
  • 7.1.3. Catharanthine tartrate

8. Catharanthine Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2. Pharmaceutical
  • 8.1.3. Food and Beverages
  • 8.1.4. Others

9. Catharanthine Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Catharanthine Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Catharanthine Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.7. Italy
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.7.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.8. United Kingdom
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.9. France
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.10. Russia
    • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.10.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.11. Netherlands
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.12. Sweden
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.13. Poland
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.13.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.14. Rest of Europe
    • 9.3.14.1. Overview
    • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Catharanthine Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.8. Japan
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.9. South Korea
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Catharanthine Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Catharanthine Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Catharanthine Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. AK Scientific Inc
  • 10.2.2. Stanford Chemicals
  • 10.2.3. Cayman Chemicals
  • 10.2.4. Bio Vision Inc
  • 10.2.5. Enzo Biochem Inc
  • 10.2.6. Hainan Yueyang Biotech Co Ltd
  • 10.2.7. Abcam
  • 10.2.8. ChemFaces
  • 10.2.9. Others

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us